Dr. Jessica Williams, Assistant Professor of Medicine, WashU Medicine Division of Rheumatology, is a dedicated rheumatologist and clinical researcher with a deep commitment to advancing our understanding of lupus, an autoimmune disease of unknown cause that disproportionately affects women, racial and ethnic minorities, and individuals from lower socioeconomic backgrounds. Her work aims to uncover the […]
From detection to treatment, mapping a new future for breast cancer. WashU Medicine physicians at Siteman Cancer Center are recognized nationally for their expertise in leading-edge breast cancer therapies. Nearly 50 specialists in surgery, breast reconstruction, medical oncology and radiation oncology, radiology and pathology are part of the Breast Cancer Program at Siteman, providing personalized treatment plans […]
Trial will assess safety, efficacy of next-generation vaccine given via nasal spray, inhalation A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug application from Ocugen, Inc. was approved by the […]
At WashU’s Global Health Center in the Institute for Public Health, teams of cardiologists, implementation scientists, and other experts are spearheading efforts to address one of the world’s most common and treatable risk factors for cardiovascular disease: hypertension. These efforts span multiple NIH/NHLBI-funded studies underway in Peru, Nigeria, India, and the United States.
In 2023, several like-minded hospitalists noticed a gap in patient care, provider knowledge, and research within the division and hospital regarding the treatment of patients with addiction. These physicians—Benjamin Hoemann, MD; Thomas Hoyt, MD; Alex Lane, MD; Randy Laine, MD; Alyssa Moller, MD; and Corey Shy, MD—decided to come together to discuss these issues and […]
The DOLF Project PI, Dr. Peter Fischer, and associate director Laura Peer traveled to Liberia in October for a mid-trial visit the site of DOLF’s clinical trial of treatment for the neglected tropical disease (NTD) onchocerciasis (also known as “river blindness”). The clinical trial is located at Bong Mines Hospital about 70 miles from the […]
Pregnant women with kidney problems face high risks for complications affecting both themselves and their unborn child. In 2022, Kelli King-Morris, MD, Associate Professor of Medicine, founded the Maternal Fetal Medicine Nephrology Clinic at WashU Nephrology to optimize the care of these patients.
Joint center harnesses AI technologies to make health care more personalized, effective, efficient
ST. LOUIS, Mo. (First Alert 4) – A new form of cancer treatment for melanoma patients has been approved by the FDA, after a clinical trial in St. Louis showed promising results.
The Bone Marrow and Stem Cell Transplant Program at the Siteman Cancer Center, located at Barnes-Jewish Hospital and Washington University School of Medicine, has reached a significant clinical achievement, completing its 10,000th transplant on September 4.
Former NHL player Kelly Chase is known as one of the toughest guys to wear a St. Louis Blues jersey, racking up more than 2,000 penalty minutes in his career. But when his Washington University medical oncologist Ramzi Abboud, MD, diagnosed him with acute myeloid leukemia in 2023, Chase learned he was facing an opponent […]
Researchers at Washington University School of Medicine in St. Louis have developed a new genomic-based approach that could aid global efforts to eliminate lymphatic filariasis, a parasitic roundworm infection spread by mosquitoes.
In September of 1992, at the age of 11, Jessi Nenkie got a double lung transplant at St. Louis Children’s Hospital.
The Hepatitis C ElimiNATION Awareness Tour, sponsored by ABBVIE, brings Hepatitis C testing to underserved communities. The WashU Infectious Diseases Division’s Bridge to Health Program partnered with other state and community organizations including Street Med STL, the Missouri Department of Social Services, the Missouri Department of health and Senior Services, and Vivent Health to provide HIV […]
These days, it’s tempting to compare COVID-19 with the common cold or flu. It can similarly leave you with a nasty cough, fever, sore throat—the full works of respiratory symptoms. And it’s also become a part of the societal fabric, perhaps something you’ve resigned yourself to catching at least a few times in your life (even if […]
In the early days of the COVID-19 pandemic, it became immediately clear to the worldwide scientific and research communities that a dire need was evolving to discover effective treatments for a rapidly increasing number of infected patients.
The cardiology team at St. Louis VA has performed the hospital’s first two patient implants of the new WATCHMAN FLX Pro left atrial appendage closure device.
Patients inspired design of state-of-the-art building on Washington University Medical Campus
Patients navigating symptomatic or growing benign thyroid nodules can now receive safe and effective, nonsurgical treatments using radiofrequency ablation (RFA) technology or percutaneous ethanol injection (PEI), provided by Washington University’s Division of Endocrinology, Metabolism and Lipid Research.
The Rural Cardiovascular Health Initiative (RCHI) is a collaboration between the American College of Cardiology and the JF Maddox Foundation, to improve cardiovascular outcomes in the rural communities of New Mexico.
The Department of Medicine is proud to announce that 150 of our faculty have been selected for the 2024 Castle Connolly Top Doctors® list. The Top Doctors® selection process is entirely merit-based. Doctors cannot pay to be listed. These doctors are best-in-class healthcare providers, embodying excellence in clinical care as well as interpersonal skills. More […]
In a world where healthcare often operates on rigid schedules and within traditional settings, there exists a growing need to adapt to the realities of those who cannot easily access or adhere to such structures. This is where organizations like Street Med STL step in, redefining healthcare delivery by taking it to the streets, quite […]
Collaboration with BJC HealthCare, Schnucks supports healthy eating to combat chronic disease
More than 184 million people, exceeding 61% of the U.S. population, are likely to have some type of cardiovascular disease (CVD) and total CVD-related costs are expected to triple to $1.8 trillion by 2050, according to projections reported in two new American Heart Association presidential advisories
May 17, 2024: “Measure Your Blood Pressure Accurately, Control It, Live Longer” The important World Hypertension Day was first held on 14 May 2005, and has since become an ever-expanding yearly event. This brief provides an update on high-impact hypertension-related research in Nigeria supported by Washington University. Hypertension, also known as raised blood pressure, affects […]
Expanded services aimed at reducing region’s high STI rates, disparities in sexual health The St. Louis area has some of the highest rates of sexually transmitted infections (STIs) in the country, with the burden falling particularly heavily on Black residents and people with sexual orientations and gender identities that are marginalized.
Rare diseases are just what their name implies – each one affects a limited number of people. But with this rarity comes unique challenges, and among the biggest challenges faced by these patients are the roadblocks they encounter with gathering information about their conditions, being properly diagnosed, and finding the best resources and treatment options […]
The multidisciplinary Structural Intervention group, including Cardiovascular Division faculty members Drs. Zajarias, Sintek, Lasala, and Quader, along with colleagues in Cardiothoracic Surgery, recently performed the first JenaValve procedure for aortic regurgitation at the Barnes-Jewish Hospital site.
DOLF researchers announce initiation of a major a new clinical trial of treatments for onchocerciasis in Liberia. The study will compare the safety and efficacy of three new combination treatments with a reference treatment of albendazole plus ivermectin.
ST. LOUIS – Barnes-Jewish Hospital is introducing the 12th sickle cell treatment center in the country. The center is revolutionizing healthcare for the underrepresented community affected by the disease.
New network to evaluate emerging technologies in diverse populations Washington University School of Medicine in St. Louis is joining a new clinical trials network launched by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to investigate emerging technologies for cancer screening, with the goal of reducing cancer-related illnesses and deaths. […]
Siteman Cancer Center, based at Barnes-Jewish Hospital and the School of Medicine, is one of the first centers nationwide to offer a newly approved cell-based immunotherapy that targets melanoma.
A new clinic headed by Ying (Maggie) Chen, MD, PhD, Associate Professor of Medicine, Nephrology, focuses on helping patients with a genetic form of renal fibrosis – autosomal dominant tubulointerstitial kidney disease (ADTKD) – which ultimately leads to chronic kidney disease (CKD).